š CVS Health Stock Rockets 15% After Smashing Targets & Boosting 2025 Profit Guidance
:max_bytes(150000):strip_icc()/GettyImages-2226653005-a5ccf9a5326942ba8d0f42fe2cf3d91c.jpg)
Wall Street's pharmacy darling just gave investors a double dose of good news.
Earnings Blowout: CVS Health crushed Q2 estimates like expired medsārevenue up 8%, EPS beating by $0.17. Suddenly that 'overweight' rating doesn't look so ironic.
2025 Vision: Management jacked full-year profit guidance higher, betting on their hybrid health-tech model. Because nothing cures investor anxiety like raised forecasts.
Street Reaction: Analysts scramble to update models while the stock gaps up. Shorts? Let's just say they're needing some Pepto.
One cynical truth: In healthcare, the real prescription is always more shareholder value.